Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,898,295,007
+$168,903,621 QoQ
Shares Held
19,286,904
-0.3% QoQ
Ownership
0.800%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#17
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $26,335,991,083 across 11 Drug Manufacturers - General names. JNJ ranks #2 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,145,229 | $6,171,342,532 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
19,286,904 | $4,898,295,007 | |
| 3 | AZN |
Astrazeneca PLC
|
25,750,245 | $4,882,761,455 | |
| 4 | ABBV |
AbbVie Inc.
|
11,548,053 | $2,905,952,055 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,873,343 | $2,425,224,575 | |
| 6 | AMGN |
Amgen Inc
|
3,816,942 | $1,382,191,036 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,421,131 | $1,316,605,688 | |
| 8 | PFE |
Pfizer Inc
|
43,233,122 | $1,041,053,576 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,898,295,007 | 19,286,904 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,729,391,386 | 19,347,862 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,879,192,279 | 18,744,587 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,606,430,866 | 19,450,064 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,889,613,602 | 18,917,274 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,955,172,446 | 17,819,419 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,676,834,199 | 18,509,433 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,047,986,395 | 18,807,765 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,715,244,427 | 18,577,206 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,927,441,676 | 18,505,858 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,837,543,059 | 18,103,503 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $2,816,324,143 | 18,082,338 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,274,317,798 | 19,782,007 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,904,066,050 | 18,735,910 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,252,195,393 | 18,410,390 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,114,441,246 | 19,064,895 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,344,273,133 | 18,839,914 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $3,264,246,065 | 18,418,135 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,980,064,375 | 17,420,146 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,660,202,159 | 16,471,840 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,750,766,576 | 16,697,624 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,720,908,586 | 16,555,574 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,682,524,787 | 17,044,890 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,522,686,589 | 16,944,429 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,444,330,109 | 17,381,285 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,317,298,412 | 17,671,764 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||